A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Accepting New Patients
Clinical Focus
Gynecologic Cancers, Laser Surgery, Ovarian Cancer and Ovarian Masses, Radical Pelvic Surgery, Robotic Gynecologic Cancer Surgery, Trophoblastic Disease, Uterine Cancer, Uterine Masses
Practice Locations
A:
Education
Residency
University of Kentucky College of Medicine
Medical SchoolUniversity of Kentucky College of Medicine
FellowshipUniversity of Southern Florida
ResidencyUniversity Of Kentucky Hospital
Board Certifications
Gynecologic Oncology
American Board of Obstetrics and Gynecology
Obstetrics and GynecologyAmerican Board of Obstetrics and Gynecology
Hospital Affiliations
- Baptist Health Medical Group
- Baptist Health Lexington
- Baptist Health Richmond
Philosophy of Care
Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.
Research
Cancer
gynecologic cancer
A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk
Cancer
gynecologic cancer
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient
Cancer
gynecologic cancer
A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer
Cancer
gynecologic cancer
A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment
Cancer
gynecologic cancer
A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
About Hope McClaine Cottrill
Insurance
Our providers accept many insurance plans. Check the Baptist Health insurance policy to make sure yours is one of them.
